<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Resources - AlzWELL</title>
    <link rel="stylesheet" href="static/styles/styles.css">
</head>
<body>
    <div class="background-image"></div>

    <nav>
        <div class="logo">AlzWELL</div>
        <ul>
            <li><a href="home.html">Home</a></li>
            <li><a href="about.html">About</a></li>
            <li><a href="ed.html">Early Detection</a></li>
            <li><a href="hiw.html">How It Works</a></li>
            <li><a href="res.html" class="active">Resources</a></li>
            <li><a href="faqs.html">FAQs</a></li>
            <li><a href="index.html">Logout</a></li>
        </ul>
    </nav>

    <header>
        <h4>Resources</h4>
    </header>

    <div class="container">
        <!-- Data Sources Section -->
        <section class="card">
            <h2>Data Sources</h2>
            <p>
                Data is at the heart of Alzheimer’s research. At AlzWELL, we use some of the most renowned datasets for MRI analysis, biomarker studies, and clinical validations. Below are detailed descriptions of the key data sources that power our platform:
            </p>
            <ul>
                <li>
                    <strong>ADNI (Alzheimer's Disease Neuroimaging Initiative):</strong> 
                    A gold-standard resource for Alzheimer’s research, ADNI provides longitudinal data across multiple modalities, including MRI, PET, and genetic data. 
                    - **Key Features:**
                        - Over 1,500 participants, including Cognitively Normal (CN), Early Mild Cognitive Impairment (EMCI), Late Mild Cognitive Impairment (LMCI), and Alzheimer’s Disease (AD).
                        - Biomarker and cerebrospinal fluid (CSF) data for detailed biological analysis.
                        - Longitudinal imaging studies for tracking disease progression.
                    - **Applications in AlzWELL:** Training our MRI-based diagnostic models, fine-tuning predictive biomarkers, and validating multi-class classification systems.
                    - **Access:** Visit <a href="https://adni.loni.usc.edu" target="_blank">ADNI Official Website</a>.
                </li>
                <li>
                    <strong>OASIS (Open Access Series of Imaging Studies):</strong> 
                    Provides free access to neuroimaging data from various populations, enabling diverse studies in healthy aging and Alzheimer’s Disease.
                    - **Key Features:**
                        - Includes over 1,000 subjects aged between 18 and 96.
                        - MRI scans from both cognitively normal and demented individuals.
                        - Offers additional data for longitudinal analysis.
                    - **Applications in AlzWELL:** Enhancing model diversity and validating feature extraction in complex imaging.
                    - **Access:** Visit <a href="https://www.oasis-brains.org/" target="_blank">OASIS Official Website</a>.
                </li>
                <li>
                    <strong>Kaggle Datasets:</strong> A platform for hosting and accessing community-shared datasets, Kaggle offers numerous Alzheimer’s-related resources.
                    - **Key Features:**
                        - Pre-processed MRI datasets for quick prototyping.
                        - Biomarker data for APOE4 studies.
                        - Synthetic data for model testing.
                    - **Applications in AlzWELL:** Rapid prototyping, exploratory analysis, and data augmentation techniques.
                    - **Access:** Visit <a href="https://www.kaggle.com/" target="_blank">Kaggle</a>.
                </li>
            </ul>
        </section>
        <br>

        <!-- Research Papers Section -->
        <section class="card">
            <h2>Research Papers</h2>
            <p>
                Groundbreaking research drives the innovations behind AlzWELL. We base our work on several key publications that have laid the foundation for Alzheimer’s diagnosis and machine learning applications.
            </p>
            <ul>
                <li><strong>Litjens et al., 2017:</strong> "A survey on deep learning in medical image analysis" explores the effectiveness of CNNs in identifying structural abnormalities in medical imaging.</li>
                <li><strong>Marcus et al., 2007:</strong> "Open Access Series of Imaging Studies (OASIS)" provides cross-sectional MRI data, a significant resource for building reliable datasets.</li>
                <li><strong>Esteva et al., 2019:</strong> "A guide to deep learning in healthcare" highlights the transformative impact of AI in diagnostics and patient care.</li>
                <li><strong>Simonyan and Zisserman, 2014:</strong> "Very deep convolutional networks for large-scale image recognition" introduces the VGG16 model, which we fine-tune for Alzheimer’s detection.</li>
                <li><strong>Pan and Yang, 2009:</strong> "A survey on transfer learning" discusses the importance of transfer learning in medical imaging tasks.</li>
            </ul>
        </section>
        <br>

        <!-- Educational Resources Section -->
        <section class="card">
            <h2>Educational Resources</h2>
            <p>We recommend the following platforms for learning more about Alzheimer’s Disease and related research:</p>
            <ul>
                <li><a href="https://www.alz.org/" target="_blank">Alzheimer’s Association:</a> A leading organization offering resources, support, and the latest research updates.</li>
                <li><a href="https://www.ncbi.nlm.nih.gov/pmc/" target="_blank">PubMed Central:</a> Access to peer-reviewed research articles and case studies.</li>
                <li><a href="https://doi.org/" target="_blank">DOI Publications:</a> Find research papers with Digital Object Identifiers (DOIs).</li>
                <li><a href="https://arxiv.org/" target="_blank">arXiv:</a> Preprints of cutting-edge AI and medical research.</li>
            </ul>
        </section>
        <br>

        <!-- Community Resources Section -->
        <section class="card">
            <h2>Community Resources</h2>
            <p>
                Join a community of researchers, caregivers, and healthcare professionals dedicated to understanding and combating Alzheimer’s Disease.
            </p>
            <ul>
                <li><strong>Forums and Discussions:</strong>
                    - Alzheimer’s Forum: A community space for discussing caregiving, symptoms, and management strategies.
                    - AI in Healthcare: Dedicated forums on machine learning applications in medicine.</li>
                <li><strong>Clinical Trials:</strong> Find active trials on platforms like ClinicalTrials.gov to contribute to Alzheimer’s research.</li>
            </ul>
        </section>
        <br>

        <!-- External Collaborations Section -->
        <section class="card">
            <h2>External Collaborations</h2>
            <p>
                AlzWELL thrives on partnerships with healthcare institutions and research centers. Below are key collaborators:
            </p>
            <ul>
                <li><strong>National Institute on Aging (NIA):</strong> Supports Alzheimer’s research through funding and resources.</li>
                <li><strong>Global Brain Consortium:</strong> Facilitates global collaboration in brain health and research.</li>
                <li><strong>AI for Good Foundation:</strong> Promotes AI-driven solutions to global healthcare challenges.</li>
            </ul>
        </section>
        <br>

        <!-- Future Data Sources -->
        <section class="card">
            <h2>Future Directions in Data</h2>
            <p>
                AlzWELL is committed to exploring new and evolving data resources to enhance diagnostic precision and scalability:
            </p>
            <ul>
                <li><strong>Multimodal Data:</strong> Incorporating genetic, behavioral, and neuropsychological assessments alongside imaging.</li>
                <li><strong>Wearable Devices:</strong> Leveraging real-time data from fitness trackers and health monitors for early dementia detection.</li>
                <li><strong>Global Datasets:</strong> Expanding collaborations to include diverse populations and underrepresented groups.</li>
            </ul>
        </section>
    </div>
</body>
</html>
